GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NuCana PLC (NAS:NCNA) » Definitions » Current Accrued Expense

NuCana (NuCana) Current Accrued Expense : $11.32 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is NuCana Current Accrued Expense?

NuCana's Current Accrued Expense for the quarter that ended in Dec. 2023 was $11.32 Mil.

NuCana's quarterly Current Accrued Expense increased from Jun. 2023 ($6.80 Mil) to Sep. 2023 ($7.85 Mil) and increased from Sep. 2023 ($7.85 Mil) to Dec. 2023 ($11.32 Mil).

NuCana's annual Current Accrued Expense declined from Dec. 2021 ($12.65 Mil) to Dec. 2022 ($12.18 Mil) and declined from Dec. 2022 ($12.18 Mil) to Dec. 2023 ($11.32 Mil).

NuCana Current Accrued Expense Historical Data

The historical data trend for NuCana's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuCana Current Accrued Expense Chart

NuCana Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only 4.38 7.31 12.65 12.18 11.32

NuCana Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.18 7.80 6.80 7.85 11.32

NuCana Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

NuCana Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of NuCana's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

NuCana (NuCana) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NuCana PLC (NAS:NCNA) » Definitions » Current Accrued Expense
Comparable Companies
ABIO CADL PTN SEEL MAIA NRXP ORGS CRIS ALGS VIRX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N04A:Germany
Address
3 Lochside Way, Edinburgh, GBR, EH12 9DT
Website
https://www.nucana.com
NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States.